SavedAdd your journal

Journals / Bozok Tıp Dergisi / 2026 / Cilt: 15 Sayı: 2

Clinical Outcomes of 100% Glistening Free Intraocular Lens Implantation

%100 Glistening Free Göz İçi Lens İmplantasyonu Sonuçlarımız

Hasan Ali Bayhan(YOZGAT BOZOK ÜNİVERSİTESİ TIP FAKÜLTESİ)0000-0002-3364-6890
Koçer Furkan Durukan(Sarıkaya Devlet Hastanesi)0000-0001-8103-7435
Seray Aslan(YOZGAT BOZOK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-8514-9450
Eyüp Erkan(YOZGAT BOZOK ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-3037-3724
Pages
139–147
Publication Date
2025-06-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was found that the ENOVA GF3 IOL was a safe lens in terms of intraoperative complications, postoperative fibrin reaction, deviation from target refraction, PCO and glistening.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The purpose of this study is to investigate the outcomes of ENOVA GF3 intraocular lens (IOL) implantation.
📊
Key Findings & Data:Materials and Methods: In this retrospective study, we evaluated the clinical results of patients undergoing phacoemulsification and implanted ENOVA GF3, a hydrophobic acrylic IOL, in XXXX ophthalmology clinic. 320 eyes of 292 patients were included in the study.
💡
Conclusion & Impact:Conclusion: It was found that the ENOVA GF3 IOL was a safe lens in terms of intraoperative complications, postoperative fibrin reaction, deviation from target refraction, PCO and glistening.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:göziçi lens · ENOVA GF3 · hidrofobik lens

Abstract

Objective: The purpose of this study is to investigate the outcomes of ENOVA GF3 intraocular lens (IOL) implantation. Materials and Methods: In this retrospective study, we evaluated the clinical results of patients undergoing phacoemulsification and implanted ENOVA GF3, a hydrophobic acrylic IOL, in XXXX ophthalmology clinic. 320 eyes of 292 patients were included in the study. All operations were performed by the same surgeon. The postoperative follow-up examinations were conducted on the 1 st and 7 th postoperative days and at the 1 st , 3 rd , 6 th and 12 th months. In these examinations, we examined uncorrected distance visual acuity, corrected distance visual acuity, uncorrected and corrected near visual acuity. Photographs of the anterior segment were taken after pupil dilation, Glistening and posterior capsule opacification (PCO) formations were noted. Deviations from the target refraction were determined by postoperative autorefractometer values. The patients underwent contrast sensitivity tests. All patients’ quality of life was determined with the National Eye Institute-Visual Function Questionnaire (NEI VFQ 25). Results: In 282 eyes (88%) the mean incision size was 2.20 and in 38 eyes (12%) it was 2.80 mm. In terms of intraoperative complications, intraoperative floppy iris (IFIS) occurred in 3 patients (0.01%) and posterior capsule rupture (PCR) occurred in 1 patient (0.003%). Evaluations at 6 and 12 months showed no glistening, PCO or any other complications. The target refraction deviation values were 0.06 ± 0.71 and the mean corrected visual acuity was 0.98 ± 20 at the 12-month evaluation after IOL implantation. Conclusion: It was found that the ENOVA GF3 IOL was a safe lens in terms of intraoperative complications, postoperative fibrin reaction, deviation from target refraction, PCO and glistening. Considering the short- and long-term results of ENOVA GF3, we suggest that it can be preferred in clinical practice.

Özet

Amaç: Bu çalışmanın amacı ENOVA GF3 göz içi lens implantasyonunun klinik sonuçlarını araştırmaktır. Gereç ve Yöntem: Bu retrospektif çalışmada, XXXXX göz kliniğinde fakoemülsifikasyon uygulanan ve hidrofobik akrilik bir göz içi lens (GİL) olan ENOVA GF3 implante edilen hastaların sonuçlarını değerlendirdik. Çalışmaya tamamı aynı cerrah tarafından opere edilen, 292 hastanın 320 gözü dahil edildi. Ameliyat sonrası takip muayeneleri ameliyat sonrası 1. ve 7. günlerde ve 1., 3., 6. ve 12. aylarda yapıldı. Bu muayenelerde düzeltilmemiş uzak görme keskinliği, düzeltilmiş uzak görme keskinliği, düzeltilmemiş ve düzeltilmiş yakın görme keskinliği incelendi. Pupil dilatasyonundan sonra ön segmentin fotoğrafları çekildi, glistening ve arka kapsül kesafeti (AKK) oluşumları not edildi. Hedef refraksiyondan sapmalar hastaların postoperatif otorefraktometre değerlerine bakılarak belirlendi. Hastalara kontrast duyarlılık testleri uygulandı. Tüm hastaların yaşam kalitesi Ulusal Göz Enstitüsü Görme Fonksiyonları Ölçeği (NEI VFQ 25) anketi ile belirlendi. Bulgular: Çalışmaya dahil edilen 282 gözün (%88) ortalama kesi boyutu 2,20 mm ve 38 gözün (%12) ortalama kesi boyutu ise 2,80 mm idi. İntraoperatif komplikasyonlar, 3 hastada (%0,01), gevşek iris (IFIS) ve 1 hastada (%0,003) arka kapsül rüptürü (AKR) idi. 6. ve 12. aydaki değerlendirmelerde ise glistening, AKK veya başka herhangi bir komplikasyon görülmedi. ENOVA GF3 implantasyonundan sonraki 12 aylık değerlendirmede hedef refraksiyon sapma değerleri 0,06 ± 0,71 ve ortalama düzeltilmiş görme keskinliği 0,98 ± 20 idi. Sonuç: ENOVA GF3 GİL, intraoperatif komplikasyonlar ve postoperatif fibrin reaksiyonu, hedef refraksiyondan sapma, AKK ve glistening açısından güvenilir bir lenstir. ENOVA GF3’ün kısa ve uzun dönem sonuçları incelendiğinde, klinik pratikte tercih edilebileceğini düşünmekteyiz.

🔖

Cite This Article

Bayhan, H. A., Durukan, K. F., Aslan, S., Erkan, E. (2025). Clinical Outcomes of 100% Glistening Free Intraocular Lens Implantation. Bozok Tıp Dergisi, Cilt: 15 Sayı: 2, 139–147. https://doi.org/10.16919/bozoktip.1547782

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (38)

  1. Gurnani B, Kaur K. Phacoemulsification. [Updated 2023 Jun 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK576419/
  2. Werner L, Thatthamla I, Ong M, Schatz H, Garcia-Gonzalez M, Gros-Otero J, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019 Oct;45(10):1490-7.
  3. Farukhi MA, Werner L, Kohl JC, Gardiner GL, Ford JR, Cole SC, et al. Evaluation of uveal and capsule biocompatibility of a singlepiece hydrophobic acrylic intraocular lens with ultraviolet-ozone treatment on the posterior surface. J Cataract Refract Surg. 2015 May;41(5):1081-7.
  4. Pagnoulle C, Bozukova D, Gobin L, Bertrand V, Gillet-De Pauw M-C. Assessment of new-generation glistening-free hydrophobic acrylic intraocular lens material. J Cataract Refract Surg. 2012;38(7):1271-7.
  5. Balendiran V, Werner L, Ellis N, Shumway C, Jiang B, Kamae K, et al. Uveal and capsular biocompatibility of a new hydrophobic acrylic microincision intraocular lens. J Cataract Refract Surg. 2020;46(3):459-64.
  6. Tetz M, Jorgensen MR. New Hydrophobic IOL Materials and Understanding the Science of Glistenings. Curr Eye Res. 2015;40(10):969-81.
  7. Blume I, Schwering P, Mulder M, Smolders C. Vapour sorption and permeation properties of poly (dimethylsiloxane) films. Journal of membrane science. 1991;61:85-97.
  8. Tognetto D, Toto L, Sanguinetti G, Ravalico G. Glistenings in foldable intraocular lenses. J Cataract Refract Surg. 2002;28(7):1211-6.
  9. Rønbeck M, Behndig A, Taube M, Koivula A, Kugelberg M. Comparison of glistenings in intraocular lenses with three different materials: 12-year follow-up. Acta Ophthalmol. 2013 Feb;91(1):66- 70.
  10. Hayashi K, Hirata A, Yoshida M, Yoshimura K, Hayashi H. Longterm effect of surface light scattering and glistenings of intraocular lenses on visual function. Am J Ophthalmol. 2012 Aug;154(2):240- 51.e2
  11. Werner L. Glistenings and surface light scattering in intraocular lenses. J Cataract Refract Surg. 2010;36(8):1398-420.
  12. Colin J, Orignac I, Touboul D. Glistenings in a large series of hydrophobic acrylic intraocular lenses. J Cataract Refract Surg. 2009;35(12):2121-6.
  13. Michael R, van Rijn LJ, van den Berg TJ, Barraquer RI, Grabner G, Wilhelm H,et al. Association of lens opacities, intraocular straylight, contrast sensitivity and visual acuity in European drivers. Acta Ophthalmol. 2009 Sep;87(6):666-71.
  14. van der Mooren M, Franssen L, Piers P. Effects of glistenings in intraocular lenses. Biomed Opt Express. 2013 Jul 11;4(8):1294-304.
  15. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001 Jul;119(7):1050-8.
  16. Lin I-C, Wang I-J, Lei M-S, Lin LL-K, Hu F-R. Improvements in vision-related quality of life with AcrySof IQ SN60WF aspherical intraocular lenses. J Cataract Refract Surg. 2008;34(8):1312-7.
  17. Kato K, Nishida M, Yamane H, Nakamae K, Tagami Y, Tetsumoto K. Glistening formation in an AcrySof lens initiated by spinodal decompositionof the polymer network bytemperature change. J Cataract Refract Surg. 2001;27(9):1493-8.
  18. Moreno-Montañés J, Alvarez A, Rodríguez-Conde R, FernándezHortelano A. Clinical factors related to the frequency and intensity of glistenings in AcrySof intraocular lenses. J Cataract Refract Surg. 2003;29(10):1980-4.
  19. Miyata A, Yaguchi S. Equilibrium water content and glistenings in acrylic intraocular lenses. J Cataract Refract Surg. 2004;30(8):1768- 72.
  20. Godlewska A, Owczarek G, Jurowski P. Glistening phenomenon in acrylic hydrophobic intraocular lenses – how do perioperative factors and concomitant diseases effect it’s incidence and severity. Klin Oczna. 2016;118(3):191-6.
  21. Dick HB, Olson RJ, Augustin AJ, Schwenn O, Magdowski G, Pfeiffer N. Vacuoles in the Acrysof intraocular lens as factor of the presence of serum in aqueous humor. Ophthalmic Res. 2001 MarApr;33(2):61-7.
  22. Manuchehri K, Mohamed S, Cheung D, Saeed T, Murray P. Brown deposits in the optic of foldable intraocular lenses in patients with uveitis. Eye. 2004;18(1):54-8.
  23. Mönestam E, Behndig A. Impact on visual function from light scattering and glistenings in intraocular lenses, a long-term study. Acta Ophthalmol. 2011 Dec;89(8):724-8.
  24. Chang A, Kugelberg M. Glistenings 9 years after phacoemulsification in hydrophobic and hydrophilic acrylic intraocular lenses. J Cataract Refract Surg. 2015 Jun;41(6):1199-204.
  25. Waite A, Faulkner N, Olson RJ. Glistenings in the single-piece, hydrophobic, acrylic intraocular lenses. Am J Ophthalmol. 2007 Jul;144(1):143-4.
  26. Chang A, Behndig A, Rønbeck M, Kugelberg M. Comparison of posterior capsule opacification and glistenings with 2 hydrophobic acrylic intraocular lenses: 5-to 7-year follow-up. J Cataract Refract Surg. 2013;39(5):694-8.
  27. Christiansen G, Durcan FJ, Olson RJ, Christiansen K. Glistenings in the AcrySof intraocular lens: pilot study. J Cataract Refract Surg. 2001;27(5):728-33.
  28. Henriksen BS, Kinard K, Olson RJ. Effect of intraocular lens glistening size on visual quality. J Cataract Refract Surg. 2015;41(6):1190-8.
  29. Gunenc U, Oner FH, Tongal S, Ferliel M. Effects on visual function of glistenings and folding marks in AcrySof intraocular lenses. J Cataract Refract Surg. 2001;27(10):1611-4.
  30. Colin J, Praud D, Touboul D, Schweitzer C. Incidence of glistenings with the latest generation of yellow-tinted hydrophobic acrylic intraocular lenses. J Cataract Refract Surg. 2012;38(7):1140-6.
  31. Auffarth GU, Brézin A, Lignereux F, Khoramnia R, Yildirim TM, Kohnen T, et al. Randomized multicenter trial to assess posterior capsule opacification and glistenings in two hydrophobic acrylic intraocular lenses. Sci Rep. 2023 Feb 17;13(1):2822.
  32. Macías-Murelaga B, Garay-Aramburu G, Bergado-Mijangos R, Coello-Ojeda D, Ozaeta I, Garcia-Gómez PJ, et al. Prediction Error Stabilization and Long-Term Standard Results with a Monofocal Intraocular Lens. Vision. 2022;6(1):5.
  33. Simon SS, Chee YE, Haddadin RI, Veldman PB, Borboli-Gerogiannis S, Brauner SC, et al. Achieving target refraction after cataract surgery. Ophthalmology. 2014 Feb;121(2):440-4.
  34. Pomerance GN, Evans DW. Test-retest reliability of the CSV1000 contrast test and its relationship to glaucoma therapy. Invest Ophthalmol Vis Sci. 1994 Aug;35(9):3357-61.
  35. Marcovich AL, Tandogan T, Bareket M, Eting E, Kaplan-Ashiri I, Bukelman A, et al. Opacification of hydrophilic intraocular lenses associated with vitrectomy and injection of intraocular gas. BMJ Open Ophthalmol. 2018 Dec 15;3(1):e000157.
  36. Virdee J, Mandal P, Brown A, Khan I. Neodymium:YAG laser posterior capsulotomy in the lateral decubitus position. Arch Clin Exp Ophthalmol 2019; 1(1):1-3.
  37. Han Y, Tang J, Xia J, Wang R, Qin C, Liu S, et al. Anti-Adhesive And Antiproliferative Synergistic Surface Modification Of Intraocular Lens For Reduced Posterior Capsular Opacification. Int J Nanomedicine. 2019 Nov 19;14:9047-61.
  38. Zhao Y, Yang K, Li J, Huang Y, Zhu S. Comparison of hydrophobic and hydrophilic intraocular lens in preventing posterior capsule opacification after cataract surgery: An updated meta-analysis. Medicine (Baltimore). 2017 Nov;96(44):e8301.